81 related articles for article (PubMed ID: 22352257)
1. [Treatment research of intermediate severity depression: what is useful for the routine patient?].
MMW Fortschr Med; 2012 Feb; 154(2):69. PubMed ID: 22352257
[No Abstract] [Full Text] [Related]
2. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
Singer A; Schmidt M; Hauke W; Stade K
Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
Möller HJ; Langer S; Schmauss M
Pharmacopsychiatry; 2007 Mar; 40(2):53-7. PubMed ID: 17447173
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
Llorca PM; Azorin JM; Despiegel N; Verpillat P
Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
[TBL] [Abstract][Full Text] [Related]
5. [A trial of treating depressive states with cipramil].
Iakovlev VA; Belinskiĭ AV; Dorovskikh IV
Voen Med Zh; 2000 Jun; 321(6):53-6. PubMed ID: 10929517
[No Abstract] [Full Text] [Related]
6. [Citalopram (Cipramil) in monotherapy of depressed outpatients].
Landowski J
Psychiatr Pol; 2000; 34(3 Suppl):1-8. PubMed ID: 11055187
[TBL] [Abstract][Full Text] [Related]
7. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
[TBL] [Abstract][Full Text] [Related]
8. Lack of desipramine toxicity with citalopram.
Ashton AK
J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
[No Abstract] [Full Text] [Related]
9. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
[TBL] [Abstract][Full Text] [Related]
10. An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).
Rao V; Spiro JR; Rosenberg PB; Lee HB; Rosenblatt A; Lyketsos CG
Int J Geriatr Psychiatry; 2006 Mar; 21(3):273-4. PubMed ID: 16477587
[TBL] [Abstract][Full Text] [Related]
11. Clinical development of citalopram.
Willetts J; Lippa A; Beer B
J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):36S-46S. PubMed ID: 10507507
[No Abstract] [Full Text] [Related]
12. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
Bschor T; Ising M; Erbe S; Winkelmann P; Ritter D; Uhr M; Lewitzka U
J Psychiatr Res; 2012 Jan; 46(1):111-7. PubMed ID: 22030468
[TBL] [Abstract][Full Text] [Related]
13. Diurnal mood variation in outpatients with major depressive disorder.
Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
[TBL] [Abstract][Full Text] [Related]
15. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
Habra ME; Baker B; Frasure-Smith N; Swenson JR; Koszycki D; Butler G; van Zyl LT; Lespérance F
J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
[TBL] [Abstract][Full Text] [Related]
16. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.
Linka T; Müller BW; Bender S; Sartory G
Neurosci Lett; 2004 Sep; 367(3):375-8. PubMed ID: 15337269
[TBL] [Abstract][Full Text] [Related]
17. Use of escitalopram in psychogenic excoriation.
Pukadan D; Antony J; Mohandas E; Cyriac M; Smith G; Elias A
Aust N Z J Psychiatry; 2008 May; 42(5):435-6. PubMed ID: 18499934
[No Abstract] [Full Text] [Related]
18. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
Zobel AW; Schulze-Rauschenbach S; von Widdern OC; Metten M; Freymann N; Grasmäder K; Pfeiffer U; Schnell S; Wagner M; Maier W
J Psychiatr Res; 2004; 38(4):377-83. PubMed ID: 15203289
[TBL] [Abstract][Full Text] [Related]
19. A surveillance study of escitalopram treatment of depressed patients.
Anders M; Tuma I; Rösslerova H
Expert Opin Pharmacother; 2008 Jan; 9(1):1-6. PubMed ID: 18076333
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
